Clinical Trial

Rosemary Infusion for Hypertension With Hypertriglyceridemia

Completed
View on ClinicalTrials.gov →
Summary
This study aimed to evaluate the effects of daily rosemary infusion consumption on blood pressure and lipid profile in patients with mild hypertension, stratified by triglyceride status. This 6-week open-label interventional study enrolled 47 patients with mild hypertension (systolic BP 140-159 mmHg and/or diastolic BP 90-99 mmHg). Participants were stratified into two groups: normal triglycerides, TG \<1.7 mmol/L, n=22 and high triglycerides, TG ≥1.7 mmol/L, n=25. Blood pressure was assessed using 24-hour ambulatory monitoring (Holter) at baseline and day 45. Comprehensive biochemical analysis included lipid profile, hepatic and renal function markers, and inflammatory parameters.
Trial Details
NCT Number NCT07352124
Lead Sponsor awatef Sassi
Conditions Hypertension With Hypertriglyceridemia
Enrollment 47 participants
Start Date 2024-09-01
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-20